Pharmaceutical Technology

MAY 29, 2023

Lexicon Pharmaceuticals (Lexicon) has received approval from the US Food and Drug Administration (FDA) for its Inpefa drug to treat heart failure. Inpefa is a once-daily oral tablet indicated as an inhibitor of sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1).

Food and Drug Administration 98

Food and Drug Administration FDA Transportation Physicians 98

Pharmaceutical Technology

MAY 5, 2023

The US Food and Drug Administration (FDA) has accepted Optinose’s supplemental new drug application (sNDA) for Xhance (fluticasone propionate) to treat chronic rhinosinusitis, which is now under review. The drug-device combination product Xhance nasal spray combines a nasal anti-inflammatory drug with an exhalation delivery system (EDS).

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Prescription 52

World of DTC Marketing

FEBRUARY 10, 2022

It isn’t real food; it is the packaged, highly refined, chemically-laden products marketed to us as “food” that is killing us and will continue to do so until we reframe what is being perpetrated on consumers in terms of addiction. . But what is it we are eating? So how do we respond?

Insurance 197

Insurance Government Food Consulting 197

pharmaphorum

DECEMBER 19, 2022

From food and fashion to gaming and technology, thousands of online influencers all over the world have built up large and active audiences in almost all industries. Physician influencers. Influencer culture has well and truly taken over the internet. HCPs use a wide variety of digital channels to connect with the medical community.

Healthcare 52

Healthcare Healthcare Media Physicians 52

Pharmaceutical Technology

FEBRUARY 20, 2023

The US Food and Drug Administration (FDA) has granted approval for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan injection) to treat geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD). Syfovre is claimed to be the first and only therapy approved for GA.

Food and Drug Administration 98

Food and Drug Administration FDA Physicians Food 98

European Pharmaceutical Review

JANUARY 19, 2023

The contribution will enable the programme to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in US communities. The Winn Award Program has so far trained 114 early-stage investigator physicians.

Food and Drug Administration 83

Food and Drug Administration Physicians Medicine Food 83

Nixon Gwilt Law

AUGUST 9, 2023

In the proposed 2024 Medicare Physician Fee Schedule (MPFS), the Centers for Medicare and Medicaid Services (CMS) proposes new CPT codes to facilitate reimbursement for healthcare providers who help patients overcome social and environmental health barriers. One of the greatest challenges facing the U.S. CMS defines SDOH as: “.including

Patients 89

Patients Physicians Transportation Management 89

Legacy MEDSearch

MARCH 27, 2023

Food and Drug Administration (FDA) 510(k) clearance for its FalloView device. The LCD screen on the handle of the device allows the physician to visualize internal patient anatomy in line with instrument insertion. Food and Drug Administration (FDA) 510(k) clearance for its FalloView device. FemDx Medsystems, Inc.,

Food and Drug Administration 52

Food and Drug Administration FDA Recruitment Physicians 52

World of DTC Marketing

JULY 17, 2022

Unpaid celebrity endorsements include venture capitalist Marc Andreessen, who says the drug completely changed his relationship with food, and Elon Musk, who has cited it on Twitter. Lamanna anticipates it could take two to three years to change the minds of primary care physicians. So far, the data for Wegovy looks excellent.

Side effects 209

Side effects Insurance Doctors Prescription 209

Legacy MEDSearch

MAY 22, 2023

Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s Orlucent® Skin Fluorescence Imaging System. Orlucent, Inc., a company focused on clinical assessment of suspicious moles, today announced the U.S. “It’s estimated that anywhere from 2% to 53% of U.S. About Orlucent Orlucent, Inc.

FDA 52

FDA Food and Drug Administration Physicians Recruitment 52

Pharmaceutical Technology

MAY 18, 2023

The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmission of a new drug application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adults with chronic kidney disease on dialysis who have had insufficient response or intolerance to a phosphate binder treatment.

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Food 52

Pharmaceutical Technology

OCTOBER 1, 2022

The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS).

Food and Drug Administration 97

Food and Drug Administration FDA Prescription Specialization 97

European Pharmaceutical Review

DECEMBER 6, 2023

The US Food and Drug Administration (FDA) has approved the first oral monotherapy treatment for adults with paroxysmal nocturnal haemoglobinuria (PNH). Novartis’ Factor B inhibitor, Fabhalta ® (iptacopan) provides comprehensive control of red blood cell (RBC) destruction, according to the company. percent for anti-C5.

Food and Drug Administration 86

Food and Drug Administration Patients Physicians Food 86

Legacy MEDSearch

MARCH 22, 2023

Food and Drug Administration (FDA) has cleared expanded Indications for Use for screening with FibroScan® , the non-invasive liver management technology by Echosens. Measurement interpretation has been expanded to all physicians with appropriate training. ” Age has been removed as the first selection probe and exam-type step.

Management 52

Management FDA Food and Drug Administration Physicians 52

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.

Food and Drug Administration 141

Food and Drug Administration Pharmacology Side effects Physicians 141

World of DTC Marketing

JUNE 6, 2022

There are many risk factors for type 2 diabetes, but one of the biggest is a poor diet high in processed foods and added sugar. They’re closely related—many processed foods quickly break down into sugar. When the body is swamped with sugar, it can become resistant to insulin.

Healthcare 174

Healthcare Healthcare Food Government 174

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Food and Drug Administration 111

Food and Drug Administration Physicians Prescription Medical 111

Pharmaceutical Technology

DECEMBER 5, 2022

Notably, Lupkynis is the first oral therapy approved by the US Food and Drug Administration (FDA) and EC for the treatment of active LN. However, the lack of in-person administration by physicians will likely also impact patient compliance.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59

eatNgage

FEBRUARY 15, 2022

With the new regulations in place, pharmaceutical companies have been forced to forgo offering extravagant gifts, making business lunches one of the most viable methods for pharmaceutical reps to present new drug treatment options to physicians. Increase the number of virtual meetings with physicians. Easy Sunshine Act Compliance.

Pharma 52

Pharma Doctors Physicians Pharmaceutical Sales 52

World of DTC Marketing

JULY 5, 2022

While the population is more worried about COVID, they are killing themselves by overeating processed food and not getting any exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise. Why don’t doctors have the “the talk”?

Insurance 200

Insurance Doctors Side effects Pharma 200

Legacy MEDSearch

SEPTEMBER 5, 2023

a medical software innovator dedicated to enhancing clinical impact in ablation therapy, announced today that it has received 510(k) clearance from the USA Food and Drug Administration (FDA) for its VisAble.IO Techsomed Ltd., “We are excited to receive 510(k) clearance for our VisAble.IO

FDA 52

FDA Food and Drug Administration Physicians Recruitment 52

Pharmaceutical Technology

JUNE 14, 2023

Ipsen has received US Food and Drug Administration (FDA) approval for Bylvay (odevixibat) to treat patients aged 12 months and above with cholestatic pruritus caused by Alagille syndrome (ALGS).

Food and Drug Administration 52

Food and Drug Administration FDA Transportation Prescription 52

Pharmaceutical Technology

FEBRUARY 24, 2023

Sanofi has received approval from the US Food and Drug Administration (FDA) for its Altuviiio [Antihemophilic Factor (Recombinant) , Fc-VWF-XTEN Fusion Protein-ehtl], to treat a type of inherited bleeding disorder known as haemophilia A. It is expected to be available commercially in April in the US.

Food and Drug Administration 59

Food and Drug Administration FDA Physicians Food 59

Clarivate

APRIL 24, 2023

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Pharmaceutical Technology

NOVEMBER 10, 2022

The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Swedish Orphan Biovitrum AB ’s (Sobi) Kineret (anakinra) to treat Covid-19 in adult patients who are hospitalised with pneumonia.

Food and Drug Administration 64

Food and Drug Administration FDA Physicians Food 64

Pharmaceutical Technology

JANUARY 25, 2023

The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure’s AVT02 (adalimumab). GlobalOne Healthcare Division CEO Ashraf Radwan said: “The approval of Simlandi by the SFDA marks an important milestone for local patients and physicians. “We

Manufacturing 59

Manufacturing Distribution Physicians Marketing 59

European Pharmaceutical Review

FEBRUARY 22, 2023

Today’s approval offers physicians and patients in the EU more flexibility to determine the right treatment plan and enables more patients to potentially benefit from this medicine,” explained Dave Fredrickson, Executive Vice President of AstraZeneca’s Oncology Business Unit.

Safety 86

Safety Medicine Physicians Food 86

pharmaphorum

DECEMBER 4, 2022

The device has been tested in animals so far, and last year Neuralink unveiled a pig called Gertrude which had a chip implanted that allowed neural activity in her snout to be transmitted and recorded as she rooted for food. — Physicians Committee (@PCRM) November 30, 2022. Take action! link] (12/12).

Side effects 110

Side effects Recruitment Physicians Food 110

Pharmaceutical Technology

APRIL 17, 2023

The US Food and Drug Administration (FDA) has approved an update to the indications and usage section of Horizon Therapeutics ’ Tepezza (teprotumumab-trbw) label to specify its use to treat thyroid eye disease (TED) patients regardless of disease activity or duration.

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Food 52

Pharmaceutical Technology

FEBRUARY 9, 2023

The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals’ Eylea (aflibercept) injection to treat the retinopathy of prematurity (ROP) in preterm infants. For the first time, physicians will now have an FDA-approved medication in Eylea to treat this heartbreaking disease in these smallest of patients.”

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Food 52

Pharma Leaders

MARCH 27, 2023

Iovance Biotherapeutics has completed submission of the Biologics License Application (BLA) for lifileucel to the US Food and Drug Administration (FDA).

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Food 52

Pharmaceutical Technology

AUGUST 8, 2022

The US Food and Drug Administration (FDA) has granted approval for Pfizer and Myovant Sciences ’ Myfembree (relugolix 40mg, estradiol 1mg and norethindrone acetate 0.5mg) to manage moderate-to-severe pain linked with endometriosis in pre-menopausal women.

Food and Drug Administration 75

Food and Drug Administration FDA Management Physicians 75

Pharmaceutical Technology

APRIL 11, 2023

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.

Safety 59

Safety Food and Drug Administration FDA Side effects 59

Pharmaceutical Technology

DECEMBER 7, 2022

GlobalData anticipates that this safety update will likely raise physician and regulator vigilance regarding long-term Dupixent use but is unlikely to impact overall prescribing patterns for the product. Sanofi and Regeneron’s Dupixent had previously been linked to conjunctivitis, an eye condition usually caused by allergies or an infection.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

Pharmaceutical Technology

JULY 12, 2022

The order is contingent on the vaccine obtaining Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) as well as the Centers for Disease Control and Prevention (CDC) recommendation. million doses of the company’s Covid-19 vaccine, NVX-CoV2373, in the initial stage.

Food and Drug Administration 64

Food and Drug Administration FDA Government Physicians 64

Legacy MEDSearch

NOVEMBER 14, 2022

Food and Drug Administration (FDA). Current and planned use cases for IntraOpVSP are expected to align to the needs of physicians across general, craniofacial and maxillofacial, neuro, orthopedic, plastic, thoracic and vascular surgery disciplines. Food and Drug Administration cleared the software for use in 2022.

Food and Drug Administration 52

Food and Drug Administration FDA Recruitment Food 52

Pharma Leaders

MAY 18, 2023

The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmitted New Drug Application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adult patients with chronic kidney disease on dialysis who have had an insufficient response or intolerance to a phosphate binder therapy.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52